The FDA’s dispute with biotech firm uniQure over Huntington’s gene therapy highlights growing tensions between innovation, ...

Balcony solar systems are quietly transforming clean energy access. Discover how plug-in solar works, its legal challenges, ...

A new U.S. autism research panel is examining potential causes of autism, sparking debate over science, policy, and the ...

Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.

Major talcum powder verdicts are reshaping corporate liability, public health debates, and mass tort litigation nationwide.

CDC faces leadership exodus amid policy disputes, raising concerns over scientific independence and outbreak readiness.

Autism researchers form an independent panel to defend evidence-based science amid controversy over changes to the U.S. federal autism advisory committee.